Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics.
Read more about cookies
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL
mei 2024
Inge M, van der Sluis, et al
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Improved Outcome for ALL by Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for Other Risk Groups
sep. 2023
Rob, Pieters, et al
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Higher incidence of delayed methotrexate clearance in pediatric acute lymphoblastic leukemia patients treated with imatinib
jan. 2023
Inge, van der Sluis, et al
EJC Pediatric Oncology
Health-related quality of life and its determinants during and after treatment for paediatric acute lymphoblastic leukaemia: a national, prospective, longitudinal study in the Netherlands
jan. 2023
Emily R., Schwartz, et al
BMJ open
Safety of mRNA-based COVID-19 vaccination in paediatric patients with a PEG-asparaginase allergy
